Related Experiment Videos
Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types
S Tisminetzky1, M Gerotto, P Pontisso
1International Center for Genetic Engineering and Biotechnology, Trieste, Italy.
Insights
Identifying hepatitis C virus (HCV) genotypes is crucial for patient management. Molecular and serological methods showed good correlation, though discrepancies occurred in a few cases, particularly in PCR-negative patients.
Area of Science:
- Virology
- Hepatology
- Clinical Diagnostics
Background:
- Hepatitis C virus (HCV) genotype identification is vital for effective clinical management.
- Accurate and reliable methods for HCV genotyping are essential for patient care.
Purpose of the Study:
- To compare the effectiveness of two different methods for determining HCV genotype in patients.
- To evaluate the correlation between molecular and serological techniques for HCV typing.
Main Methods:
- HCV genotyping was performed using a dot-blot assay with type-specific probes from the 5'-UTR.
- HCV serotyping utilized an ELISA system detecting type-specific antibodies against the NS4 region.
- Both methods were applied to samples from 127 patients infected with HCV.
Main Results:
- A good overall correlation was observed between the dot-blot genotyping and ELISA serotyping methods.
- Discrepancies were noted in 4 patients, with HCV-2 and HCV-3 genotypes misidentified as HCV-1 by serotyping.
- No mixed infections were detected, and no specific serotype profile was observed in 19 PCR-negative sera.
Conclusions:
- Molecular and serological techniques are nearly equivalent for determining HCV viral type.
- The clinical significance of serotyping results in individual cases, especially in PCR-negative patients, requires further investigation.
Abstract:
The usefulness of identification of hepatitis C virus (HCV) genotype has recently been investigated for the clinical management of patients infected by HCV. In the present study, the HCV genotype infecting 127 patients was determined by two different methods: HCV genotyping using a dot-blot assay with type-specific probes derived from the 5'-UTR of HCV genome and HCV serotyping using an ELISA system in which type-specific antibodies against the NS4 region were detected. Overall, a good correlation of the two methods was observed, the main discrepancy being 4 patients with sequence-confirmed HCV-2 (2 cases) and HCV-3 (2 cases) genotypes recognized as HCV-1 by serotyping. Mixed infections were not detected by either method. In 19 PCR negative sera, in which the HCV genotype could not be evaluated, no particular serotype profile was observed. In conclusion, the molecular and serological techniques are almost equivalent in determining the viral type, although in individual cases, especially in PCR negative patients, the clinical meaning of the serotyping result remains to be determined.